(PDN) Invesco FTSE RAFI Developed - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E7351

Common Stocks, Small Cap, Mid Cap, Developed Markets, Ex US

Description: PDN Invesco FTSE RAFI Developed

The Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF (PDN) is an exchange-traded fund that tracks the performance of small and mid-sized companies in developed markets outside the United States. The fund invests at least 90% of its assets in the securities that comprise its underlying index, which is comprised of approximately 1,500 common stocks.

The index is constructed using a fundamental weighting methodology, which considers four key measures of company size: book value plus intangibles, adjusted cash flow, adjusted sales, and dividend plus buybacks. This approach allows the fund to capture the performance of companies with strong fundamentals, potentially reducing the impact of market volatility.

From a performance perspective, key metrics to evaluate PDN include its tracking error, expense ratio, and dividend yield. A low tracking error indicates that the fund is effectively replicating its underlying index, while a competitive expense ratio is essential for long-term returns. Additionally, the dividend yield can provide insight into the funds income generation potential.

To further assess PDNs investment potential, its essential to examine its sector allocation, geographic distribution, and holdings turnover. A diversified sector allocation and geographic distribution can help mitigate risk, while a low holdings turnover may indicate a more stable investment approach. By analyzing these metrics, investors can gain a deeper understanding of PDNs underlying characteristics and make more informed investment decisions.

PDN ETF Overview

Market Cap in USD 365m
Category Foreign Small/Mid Value
TER 0.49%
IPO / Inception 2007-09-27

PDN ETF Ratings

Growth Rating 74.9%
Fundamental -
Dividend Rating 64.1%
Return 12m vs S&P 500 5.32%
Analyst Rating -

PDN Dividends

Dividend Yield 12m 3.27%
Yield on Cost 5y 4.67%
Annual Growth 5y 11.38%
Payout Consistency 85.1%
Payout Ratio %

PDN Growth Ratios

Growth Correlation 3m 93%
Growth Correlation 12m 79.8%
Growth Correlation 5y 25.3%
CAGR 5y 18.63%
CAGR/Max DD 3y 1.41
CAGR/Mean DD 3y 7.69
Sharpe Ratio 12m 1.75
Alpha 0.00
Beta 0.954
Volatility 12.15%
Current Volume 8.5k
Average Volume 20d 15.2k
Stop Loss 40.4 (-3%)
Signal -0.30

What is the price of PDN shares?

As of September 18, 2025, the stock is trading at USD 41.65 with a total of 8,548 shares traded.
Over the past week, the price has changed by +1.10%, over one month by +3.40%, over three months by +10.99% and over the past year by +24.83%.

Is Invesco FTSE RAFI Developed a good stock to buy?

Yes. Based on ValueRay's Analyses, Invesco FTSE RAFI Developed (NYSE ARCA:PDN) is currently (September 2025) a good stock to buy. It has a ValueRay Growth Rating of 74.88 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PDN is around 41.24 USD . This means that PDN is currently overvalued and has a potential downside of -0.98%.

Is PDN a buy, sell or hold?

Invesco FTSE RAFI Developed has no consensus analysts rating.

What are the forecasts/targets for the PDN price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 46.4 11.4%

Last update: 2025-09-12 04:42

PDN Fundamental Data Overview

Market Cap USD = 365.3m (365.3m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 1.07
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 365.3m USD (365.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 365.3m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 365.3m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(365.3m)/V(0.0) * Re(9.53%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.53% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for PDN ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle